Where does Ben Scruggs work?

Ben Scruggs is Principal at Hatteras Venture Partners.

What check size does Ben Scruggs write?

Ben Scruggs typically writes checks of $100K – $5M.

Where did Ben Scruggs go to school?

Ben Scruggs studied at Washington University School of Medicine in St. Louis (PhD, Molecular Cell Biology); Vanderbilt University (B.E., Biomedical Engineering); HBX | Harvard Business School (CORe: Credential of Readiness).

Ben Scruggs

Investor

Principal at Hatteras Venture Partners · Manager at L2 Ventures

Raleigh-Durham / Southeast US

Writes $100K – $5M checks · typically $1.5M

Find your path to Ben

230 people in our graph share verified history with Ben — schools, employers, funds. One of them is your warm intro.

Uri LopatinunlockedBen: together at National Institutes of Health (2004–2005)

×2Ben: together at HBX | Harvard Business School

×2Ben: together at Vanderbilt University

Ben: together at National Institute of Environmental Health Sciences (NIEHS)

About

Ben Scruggs is CEO of Altis Biosystems, where he oversees commercialization of a human intestinal platform derived from stem cells for applications in ADME assessment, toxicity, inflammation, metabolism, and epithelial repair. He is also a Partner at Hatteras Venture Partners, investing in biotechnology and life science tools companies and advising on strategy and commercialization. Scruggs serves on the boards of IMMvention Therapeutix and Veralox Therapeutics.

Contact· self-published, not guessed

b•••@hatterasvp.comreveal

Experience

Hatteras Venture PartnersPartnercurrent2025 — present
Hatteras Venture PartnersPrincipal2021 — 2024
Hatteras Venture PartnersAssociate2017 — 2021
Hatteras Venture PartnersAnalyst2017Raleigh-Durham-Chapel Hill Area
Hatteras Venture PartnersHatteras Fellow2016Raleigh-Durham-Chapel Hill Area
Altis BiosystemsChairman & CEOcurrent2023 — present
VERALOX TherapeuticsBoard Membercurrent2021 — present
IMMvention Therapeutix, Inc.Board Membercurrent2020 — present
L2 VenturesManagercurrent2020 — present
Tune TherapeuticsSr. Director, Strategic Initiatives2022 — 2023
National Institute of Environmental Health Sciences (NIEHS)Postdoctoral Fellow2013 — 2016
Washington University School of MedicinePh.D. Candidate in Molecular Cell Biology2006 — 2012
Vanderbilt University Medical CenterUndergraduate research2003 — 2006
National Institutes of HealthSummer Research Intern2004 — 2005
LSU Health Sciences CenterSummer research intern2003
LSU Health Sciences CenterScience and Medicine Academic Research Training Program2001 — 2002

Skills & more

NAMs (New Approach Methodologies)1ADME / DMPK1Intestinal permeabilityBioavailabilityCell Biology19Molecular Biology15Confocal Microscopy10Genomics5Western Blotting4qPCR3Cell Culture4Proteomics3

+11 more

Venture CapitalBoard GovernanceFundraisingBiotechnologyDue DiligenceMicroscopyImmunohistochemistryRNA biologyGene ExpressionTranscriptional RegulationLife Sciences

From Ben's professional profile.

Colleagues at Hatteras Venture Partners

Alston Gardner

Special Advisor at Hatteras Venture Partners

Ben Scruggs, PhD

Partner at Hatteras Venture Partners

Christy Shaffer

General Partner at Hatteras Venture Partners

Christy Shaffer, PhD

General Partner at Hatteras Venture Partners

Clay Thorp

General Partner at Hatteras Venture Partners

Declan Devens

Operations Analyst at Hatteras Venture Partners

Douglas Reed

General Partner at Hatteras Venture Partners

Douglas Reed, MD

General Partner at Hatteras Venture Partners

Network5

Christy Shaffer

General Partner at Hatteras Venture Partners

Clay Thorp

General Partner at Hatteras Venture Partners

Don Rose

Venture Partner at Hatteras Venture Partners

Fred Goldwater

Digital Health Advisor at Excelerate Health Ventures

Holden Thorp

Venture Partner at Hatteras Venture Partners

Investors connected to Ben in public investor directories — a warm-intro map.

Frequently asked questions

Who is Ben Scruggs?: Ben Scruggs is CEO of Altis Biosystems, where he oversees commercialization of a human intestinal platform derived from stem cells for applications in ADME assessment, toxicity, inflammation, metabolism, and epithelial repair. He is also a Partner at Hatteras Venture Partners, investing in biotechnology and life science tools companies and advising on strategy and commercialization. Scruggs serves on the boards of IMMvention Therapeutix and Veralox Therapeutics.
Where does Ben Scruggs work?: Ben Scruggs is Principal at Hatteras Venture Partners.
What check size does Ben Scruggs write?: Ben Scruggs typically writes checks of $100K – $5M.
Where did Ben Scruggs go to school?: Ben Scruggs studied at Washington University School of Medicine in St. Louis (PhD, Molecular Cell Biology); Vanderbilt University (B.E., Biomedical Engineering); HBX | Harvard Business School (CORe: Credential of Readiness).

Founder mafias

Vanderbilt University mafia98

Also came through, then founded or led a company.

Charles D. KingBachelor of Arts (B.A.)Founded MaC Venture Capital +1 Adam JacksonBSFounded Doctor on Demand +1 Andy RinkBEFounded Playgroundpediatrics +1 Christopher BulowB.A.Founded Viosera +1 Pauline RotetaBachelor of Engineering (BE)Founded Pasito +1 Curtis NorthcuttBachelor of ScienceFounded ChipBrain +1

+ 91 more

Harvard Business School Online mafia87

Also came through, then founded or led a company.

Viswa Colluru, PhDHBX Core: Credential of ReadinessFounded Enveda Therapeutics, Inc. +2 Jinal JhaveriDisruptive Strategy by Clayton Christensen,NegotiationFounded SchoolMint +1 Sasha OrloffContinuing EducationFounded LendUp +1 Brian VallelungaStrategy and LeadershipFounded Doppler Technologies Inc +1 Upeka BeeThe Leadership Consortium by Frances FreiFounded DianaHR +1 Matthew GlickOther; "Core: Credential of Readiness"Founded Gipper +1

+ 80 more

Washington University School of Medicine in St. Louis mafia14

Also came through, then founded or led a company.

Ansuman SatpathyDoctor of Philosophy (Ph.D.)Founded Santa Ana +4 Eric LeuthardtChief Resident & Resident PhysicianFounded Inner Cosmos +3 Reid HuberPhDFounded MOMA Therapeutics +2 Nicholas GoldnerDoctor of PhilosophyFounded Viosera +1 Corey M. McCannMD/PhDFounded T.Rx Capital +1 Dave MessinaMaster of Science (MS)Founded Cofactor Genomics

+ 7 more

Hatteras Venture Partners mafia4

Also came through, then founded or led a company.

Myla Lai-GoldmanVenture PartnerFounded GeneCentric Malcolm KendallPartnerFounded Microbiome Insights Inc.Heather MadsenOperating PartnerFounded PIPr Therapeutics

Tune Therapeutics mafia3

Also came through, then founded or led a company.

Derek JantzExecutive OfficerFounded Precision BioSciences Charles GersbachDirectorFounded Locus Biosciences

Same school

Also attended Washington University School of Medicine in St. Louis21

Reid HuberPartner at Third Rock Ventures David CohnInterim Chief Executive Officer and Chief Medical Officer at Oncology Ventures Glenn PierceScientific Advisory Group Co-Chair at Pathway to Cures Daguang WangManaging Director at Yonjin Venture LLC Dave VreelandSenior Managing Partner at Caduceus Capital Partners Dana WattPartner at Breakout Ventures

+ 15 more

Also attended Vanderbilt University351

Jacob JofeInvestor at Index Ventures Ross Perot Jr.Chairman of The Perot Group at Perot Jain David JohnsonManaging Director at Intel Capital, North America Tom DriscollPrincipal at Differential Ventures Sabina SmithPrincipal at Scale Venture Partners Payton DobbsOperating Partner at Hoxton Ventures

+ 345 more

Also attended HBX | Harvard Business School245

MariaInvestor at Investinor Kelsey BeausoleilBusiness Development Network at Redpoint Ventures Oliver MarquesPartner, Capital Formation at March Capital Partners John DemeterInvestor at Khosla Ventures Jeff RoseAdvisor at AI Capital RobAdvisor at TFX Capital

+ 239 more

Shared employers

Also worked at National Institute of Environmental Health Sciences (NIEHS)2

Karthik RamasubramanianVenture Associate at Black Opal Ventures Timothy ChangManaging Director at Goodwater Capital

Also worked at Washington University School of Medicine30

Victoria GraceFounding partner of Colle Capital Partners, an opportunistic early-stage technology venture fund Karlos BledsoePrincipal at Seae Ventures Mukund SubramanianStrategic Advisor at Advance Venture Partners Andrew WegrzynPrincipal at SixThirty Ventures Stephanie RenInvestment Associate at Builders VC Travis ManascoPrincipal at Solas BioVentures

+ 24 more

Also worked at Vanderbilt University Medical Center16

Bruce EvansSenior Advisor and former Managing Director of Summit Partners Jonathan SadloweFounder and General Partner at Gossamer Capital Jack McGuireResearch Associate at Casdin Capital Matthew McGirtGeneral Partner at Mammoth Research Michihiko WadaChief Regulatory and Development Officer at Newton Biocapital Alexander StatnikovInvestor at AV8 Ventures

+ 10 more

Also worked at National Institutes of Health93

Jun JeonInvestor at Khosla Ventures Uri LopatinInvestor at Khosla Ventures Max ColbertPhysician-Entrepreneur at Medical Excellence Capital Leela SrinivasanCEO, Parity at Bull City Venture Partners Victoria GraceFounding partner of Colle Capital Partners, an opportunistic early-stage technology venture fund Ashok SrinivasanChief Science Advisor at AIF

+ 87 more